Χώρα: Ηνωμένο Βασίλειο
Γλώσσα: Αγγλικά
Πηγή: MHRA (Medicines & Healthcare Products Regulatory Agency)
Cimetidine
Rosemont Pharmaceuticals Ltd
A02BA01
Cimetidine
40mg/1ml
Oral solution
Oral
No Controlled Drug Status
Valid as a prescribable product
BNF: 01030100; GTIN: 5016119171390
CIMETIDINE 200MG/5ML ORAL SOLUTION n READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE n Keep this leaflet. You may need to read it again n If you have any further questions, ask your doctor or pharmacist n This medicine has been prescribed for you. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours n If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist. IN THIS LEAFLET: 1. What is Cimetidine Oral Solution and what is it used for 2. Before you take Cimetidine Oral Solution 3. How to take Cimetidine Oral Solution 4. Possible side effects 5. How to store Cimetidine Oral Solution 6. Further information PATIENT INFORMATION LEAFLET _Continued overleaf_ TELL YOUR DOCTOR IF YOU GET ANY OF THESE SIDE EFFECTS: n diarrhoea n feeling tired n breast swelling in men and impotence n headache, fever and dizziness n hallucinations (seeing or hearing things that are not there) n hair loss n skin rash n joint or muscle pain. If any of the side effects get serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist. 5. HOW TO STORE CIMETIDINE ORAL SOLUTION n Keep out of the reach and sight of children n Do not store above 25°C and keep out of direct sunlight n Do not use 1 month from the date you first open it n Do not use after the expiry date which is stated on the label and carton (exp: month, year) n The expiry date refers to the last day of that month n Do not use Cimetidine Oral Solution if you notice that the appearance or smell of your medicine has changed. Talk to your pharmacist n Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment. 6. FURTHER INFORMATION WHAT CIMETIDINE ORAL SOLUTION CONTAINS n The active ingredient is cimetidine n The other ingredients are methyl hydroxybenzoate (E218) Διαβάστε το πλήρες έγγραφο
OBJECT 1 CIMETIDINE 200MG/5ML ORAL SOLUTION Summary of Product Characteristics Updated 14-Jun-2013 | Rosemont Pharmaceuticals Limited 1. Name of the medicinal product Cimetidine 200mg/5ml Oral Solution 2. Qualitative and quantitative composition Cimetidine 200mg/5ml For excipients see 6.1. 3. Pharmaceutical form Oral Solution Clear yellow/orange colour with odour of peppermint and peach 4. Clinical particulars 4.1 Therapeutic indications Cimetidine is indicated in the treatment of duodenal and benign gastric ulceration, including that associated with non-steroidal anti-inflammatory agents, recurrent and stomal ulceration, oesophageal reflux disease and other conditions where reduction of gastric acid by cimetidine has been shown to be beneficial: persistent, dyspeptic symptoms with or without ulceration, particularly meal-related upper abdominal pain, including such symptoms associated with non-steroidal anti-inflammatory agents; the prophylaxis of gastro-intestinal haemorrhage from stress ulceration in seriously ill patients; before general anaesthesia in patients thought to be at risk of acid aspiration (Mendelson's) syndrome, particularly obstetric patients during labour; to reduce malabsorption and fluid loss in the short bowel syndrome; and in pancreatic insufficiency to reduce degradation of enzyme supplements. Cimetidine is also recommended in the management of the Zollinger-Ellison syndrome. 4.2 Posology and method of administration For oral administration only. The total daily dose should not exceed 2.4g. Dosage should be reduced in patients with impaired renal function (_see Special warnings and precautions for use)_ Adults: For patients with _duodenal or benign gastric ulceration_, a single daily dose of 800mg at bedtime is recommended. Otherwise the usual dosage is 400mg twice a day with breakfast and at bedtime. Other effective regimens are 200mg three times a day with meals and 400mg at bedtime (1.0g/day) and, if inadequate, 400mg four times a day (1.6g/day) also with meals and at bedtime. Treatment Διαβάστε το πλήρες έγγραφο